INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹332 Cr | ₹288 Cr | ₹265 Cr | ₹213 Cr | ₹139 Cr |
What is the latest Sundry Debtors ratio of INNOVA CAPTAB ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹332 Cr |
| Mar2024 | ₹288 Cr |
| Mar2023 | ₹265 Cr |
| Mar2022 | ₹213 Cr |
| Mar2021 | ₹139 Cr |
How is Sundry Debtors of INNOVA CAPTAB Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹332 Cr | 14.96 | |
| Mar2024 | ₹288 Cr | 8.77 | |
| Mar2023 | ₹265 Cr | 24.70 | |
| Mar2022 | ₹213 Cr | 53.51 | |
| Mar2021 | ₹139 Cr | - | |
Compare Sundry Debtors of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹4,836.8 Cr | -4% | 16.6% | -3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,610.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,279.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,649.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,469.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,955.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -4% |
16.6% |
-3.7% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses